Annual report [Section 13 and 15(d), not S-K Item 405]

Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details)

v3.25.0.1
Equity-Based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details) - Stock Appreciation Rights (SARs) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Shares    
Beginning balance outstanding, shares (in shares) 112,000  
Granted, shares (in shares) 4,000  
Exercised, shares (in shares) 0 0
Forfeited, shares (in shares) (5,000)  
Expired, shares (in shares) (87,000)  
Ending balance outstanding, shares (in shares) 24,000 112,000
Exercisable, shares (in shares) 10,000  
Weighted-average exercise price    
Weighted average exercise price, outstanding (in dollars per share) $ 66.61 $ 63.88
Granted, weighted-average exercise price (in dollars per share) 50.85  
Exercised, weighted-average exercise price (in dollars per share) 0  
Forfeited, weighted-average exercise price (in dollars per share) 55.00  
Expired, weighted-average exercise price (in dollars per share) 62.98  
Exercisable, weighted-average exercise price (in dollars per share) $ 75.79  
Weighted-average remaining contractual term    
Weighted-average remaining contractual term, outstanding (years) 2 years 1 month 6 days 1 year 1 month 6 days
Exercisable, weighted-average remaining contractual term (years) 2 years 1 month 6 days  
Aggregate Intrinsic Value    
Aggregate intrinsic value, outstanding $ 0 $ 0
Exercisable, aggregate intrinsic value $ 0